Gilead Sciences (GILD) Tops Q3 EPS by 38c, Offers Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $123.79 +0.02%
EPS Growth %: -462.7%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -462.7%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.29, $0.38 better than the analyst estimate of $1.91. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.81 billion.
GUIDANCE:
Gilead Sciences sees FY2023 EPS of $6.65-$6.85, versus the consensus of $6.25. Gilead Sciences sees FY2023 revenue of $26.7-26.9 billion, versus the consensus of $25.3 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Middleby board approves spin-off of food processing unit Midera
- Tutor Perini launches $400M senior notes offering due 2033
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
